24/7MN – Clovis Oncology Inc. (NASDAQ: CLVS) Continues to Squeeze Higher and may be preparing to challenge 200 DMA

(24/7 MARKET NEWS) Clovis Oncology Inc. (NASDAQ:CLVS) remains one of the most heavily shorted stocks, with a reported 29.08% short interest ratio and 4.4 days to cover. We’ve covered Clovis, since early in this move and, despite the daily moving averages being out of whack, really like the set up and wave pattern. We hope that it doesn’t spike too much

[mstock id=”73007″ asset=”clvs”]

It’s up $0.4072 (+22.62%), at $2.2072, on 8,589,379 shares, and it looks like it may have a go at its 200 day simple moving average resistance that’s just above $2.50.

We hope that it doesn’t spike too much and outrun its support, but, if it does, the meme traders and momo players could turbo charge its moves from there.

24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.